Skip to main content
. 2023 Feb 23;11(1):e003197. doi: 10.1136/bmjdrc-2022-003197

Table 5.

The ORs of diabetic nephropathy for predictive log-transformed hsCRP level derived from weighted and unweighted genetic risk score

Variables
n
Diabetic nephropathy
Yes, n (%) Crude OR (95% CI) Adjusted OR (95% CI)* Adjusted OR (95% CI)†
That of log-transformed hsCRP from unweighted genetic risk score
Per 1 unit 2332 256 (10.98) 1.80 (1.52 to 2.14)*** 1.80 (1.52 to 2.14)*** 1.80 (1.51 to 2.14)***
Tertile 1: <0.008 769 47 (6.11) 1.00 1.00 1.00
Tertile 2: 0.008~0.464 771 74 (9.60) 1.63 (1.12 to 2.39)* 1.63 (1.12 to 2.39)* 1.70 (1.16 to 2.49)**
Tertile 3: >0.464 792 135 (17.05) 3.16 (2.23 to 4.47)*** 3.16 (2.23 to 4.47)*** 3.19 (2.24 to 4.55)***
That of log-transformed hsCRP from weighted genetic risk score
Per 1 unit 2332 256 (10.98) 1.71 (1.44 to 2.02)*** 1.71 (1.45 to 2.02)*** 1.67 (1.40 to 1.98)***
Tertile 1: <−0.012 770 51 (6.62) 1.00 1.00 1.00
Tertile 2: −0.012~0.464 769 73 (9.49) 1.48 (1.02 to 2.15)* 1.48 (1.02 to 2.15)* 1.45 (1.00 to 2.11)
Tertile 3: >0.464 793 132 (16.65) 2.82 (2.00 to 3.96)*** 2.82 (2.01 to 3.97)*** 2.69 (1.89 to 3.82)***

*p<0.05; **p<0.01; ***p<0.001.

*Adjusted OR: adjusting for residual and PCA.

†Adjusted OR: adjusting for residual, PCA and covariates that did not satisfy the MR assumption 2, respectively.

hsCRP, high-sensitivity C-reactive protein level.